Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Accounts Payable
$2,964 Mil (As of Sep. 2015)

Teva Pharmaceutical Industries Ltd's quarterly accounts payable declined from Mar. 2015 ($3,036 Mil) to Jun. 2015 ($2,976 Mil) and declined from Jun. 2015 ($2,976 Mil) to Sep. 2015 ($2,964 Mil).

Teva Pharmaceutical Industries Ltd's annual accounts payable declined from Dec. 2012 ($3,376 Mil) to Dec. 2013 ($3,317 Mil) and declined from Dec. 2013 ($3,317 Mil) to Dec. 2014 ($3,171 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Accts Payable 1,8853,3291,3832,2442,6802,5253,7433,3763,3173,171

Teva Pharmaceutical Industries Ltd Quarterly Data

Accts Payable 3,1073,0493,3173,1433,0262,8943,1713,0362,9762,964
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership